Buyout of NovaMed Prompts Shareholder Claims Investigation by Goldfarb Branham Law Firm LLP
25 Gennaio 2011 - 7:49PM
Business Wire
Goldfarb Branham LLP is investigating whether the Board of
Directors of NovaMed, Inc. (NASDAQ: NOVA) violated shareholder
protection laws by agreeing to sell the company to Surgery Center
Holdings, Inc. for $13.25 per share. Shareholders – or anyone with
knowledge of the transaction – are encouraged to contact Hamilton
Lindley at 877-583-2855 or hlindley@goldfarbbranham.com.
“This transaction appears undervalued because the buyout price
offers no premium over the $13.00 share price that NovaMed stock
traded for as recently as January 18, 2011, and also because at
least one analyst believes that the stock is worth $18 per share,”
said securities lawyer Hamilton Lindley. “Our proposed class action
lawsuit seeks to maximize the amount of money and information to
shareholders of NovaMed in this transaction."
Goldfarb Branham’s lawyers have significant experience
representing individual and institutional investors in over 100
shareholder class action cases. A firm securities lawyer, Hamilton
Lindley, can be reached at hlindley@goldfarbbranham.com or
877-583-2855 to discuss the impact of this buyout on NovaMed
shareholders.
Grafico Azioni Novamed (NASDAQ:NOVA)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Novamed (NASDAQ:NOVA)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Novamed, Inc. (MM) (NASDAQ): 0 articoli recenti
Più Goldfarb Branham LLP Articoli Notizie